Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients

NCT04801667 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

3371

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV Infection
Coronavirus Infection
Vaccine Adverse Reaction

Interventions

BIOLOGICAL: Coronavac

Sponsor

Hospital do Rim e Hipertensão